225 related articles for article (PubMed ID: 21664196)
1. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann FA; Rogers GB; Marsh P; Lilley AK; Daniels TW; Carroll MP; Hoffman LR; Jones G; Allen CE; Patel N; Forbes B; Tuck A; Bruce KD
J Cyst Fibros; 2011 Sep; 10(5):357-65. PubMed ID: 21664196
[TBL] [Abstract][Full Text] [Related]
2. Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?
Deschaght P; Schelstraete P; Van Simaey L; Vanderkercken M; Raman A; Mahieu L; Van Daele S; De Baets F; Vaneechoutte M
PLoS One; 2013; 8(11):e79010. PubMed ID: 24312174
[TBL] [Abstract][Full Text] [Related]
3. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
[TBL] [Abstract][Full Text] [Related]
4. Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.
Billard-Pomares T; Herwegh S; Wizla-Derambure N; Turck D; Courcol R; Husson MO
J Med Microbiol; 2011 Feb; 60(Pt 2):157-161. PubMed ID: 20947668
[TBL] [Abstract][Full Text] [Related]
5. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
6. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers.
Kerem E
Pediatr Pulmonol Suppl; 1997; 16():265-6. PubMed ID: 9443305
[No Abstract] [Full Text] [Related]
7. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
[TBL] [Abstract][Full Text] [Related]
9. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
10. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.
Quittner AL; Modi AC; Wainwright C; Otto K; Kirihara J; Montgomery AB
Chest; 2009 Jun; 135(6):1610-1618. PubMed ID: 19447923
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.
Zemanick ET; Wagner BD; Harris JK; Wagener JS; Accurso FJ; Sagel SD
Pediatr Pulmonol; 2010 Jun; 45(6):569-77. PubMed ID: 20503282
[TBL] [Abstract][Full Text] [Related]
12. 2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent
Zain NMM; Webb K; Stewart I; Halliday N; Barrett DA; Nash EF; Whitehouse JL; Honeybourne D; Smyth AR; Forrester DL; Knox AJ; Williams P; Fogarty A; Cámara M; Bruce KD; Barr HL
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34596013
[No Abstract] [Full Text] [Related]
13. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
14. PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review.
Deschaght P; Van Daele S; De Baets F; Vaneechoutte M
J Cyst Fibros; 2011 Sep; 10(5):293-7. PubMed ID: 21684819
[TBL] [Abstract][Full Text] [Related]
15. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.
Taylor RF; Hodson ME; Pitt TL
Thorax; 1993 Oct; 48(10):1002-5. PubMed ID: 8256228
[TBL] [Abstract][Full Text] [Related]
16. [Physiopathology of cystic fibrosis and of infections associated to this disease].
Aramă SS; Aramă V; Cercel AS; Ion DA; Hristea A; Sotcan M
Pneumologia; 2007; 56(4):202-7. PubMed ID: 18320796
[TBL] [Abstract][Full Text] [Related]
17. [Nocardia farcinica infection in a patient with cystic fibrosis].
Beucher J; Belleguic C; Brinchault G; Deneuville E; Donnio PY; Roussey M
Rev Mal Respir; 2010; 27(1):76-9. PubMed ID: 20146956
[TBL] [Abstract][Full Text] [Related]
18. Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients.
Barthe C; Nandakumar S; Derlich L; Macey J; Bui S; Fayon M; Crouzet M; Garbay B; Vilain S; Costaglioli P
Lett Appl Microbiol; 2015 Nov; 61(5):423-8. PubMed ID: 26174137
[TBL] [Abstract][Full Text] [Related]
19. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
Mangiaterra G; Amiri M; Di Cesare A; Pasquaroli S; Manso E; Cirilli N; Citterio B; Vignaroli C; Biavasco F
BMC Infect Dis; 2018 Dec; 18(1):701. PubMed ID: 30587160
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]